BACKGROUND

Leprosy continues to pose significant health challenges globally, leading to stigma and disability when left untreated. Patient education is crucial in addressing these challenges. While traditional health lectures (THL) are widely used, they face limitations such as inconsistent delivery and low patient engagement. Video-based education (VBE) offers a more modern, scalable alternative, enhancing learning through immersive technology.

OBJECTIVES

This study compared the effectiveness of VBE versus THL in improving leprosy patients’ understanding, perspectives, and quality of life (QoL) in a tertiary hospital in the Philippines

METHODS

A randomized controlled trial with 1:1 allocation ratio was conducted among 57 leprosy patients, divided into VBE and THL groups. Baseline and post-intervention questionnaires measured understanding, patient perspectives, and QoL using the Dermatology Life Quality Index, collected immediately after and two weeks post-intervention. Statistical analyses included chi-squared tests, t-tests, and Pearson’s correlations.

RESULTS

VBE significantly improved patients’ understanding, perspectives, and QoL compared to THL. Post-intervention, 43% of VBE participants showed a high level of understanding, versus 24% in the THL group (p = 0.048). VBE had greater positive impact on patient perspectives and QoL (p = 0.011 and p = 0.046). Knowledge retention was higher in VBE group after two weeks (p = 0.0373), with improvements in understanding strongly linked to better perspectives and QoL (r = 0.54 and r = 0.65).

CONCLUSION

VBE proved more effective than THL in enhancing understanding and retention, perspectives, and QOL. With its multi-sensory, scalable format, VBE offers a promising and efficient tool for patient education, particularly in resource-limited settings.

Leprosy ; Health Education ; Educational Technology ; Multimedia

Toxic epidermal necrolysis (TEN) is a rare, life-threatening dermatological emergency characterized by extensive epidermal necrosis and detachment, along with significant mucous membrane erosions and systemic symptoms. While conventional medications such as sulfonamides and anticonvulsants are known triggers, recent reports suggest that herbal medications can also induce TEN. This case report highlights the development of TEN in a patient with invasive cervical cancer following the use of an herbal supplement.

A 48-year-old Filipino woman with newly diagnosed invasive cervical cancer developed TEN after taking an herbal supplement containing 23 botanical extracts. Despite discontinuing the supplement, her condition rapidly worsened, with vesicles and bullae progressing to epidermal detachment over 90% of her body surface area. A histopathological examination confirmed the diagnosis of TEN. The patient was treated with systemic corticosteroids and supportive care, achieving full recovery within 14 days.

This case underscores the potential risks associated with herbal medications, particularly in vulnerable patients such as those with cancer. Although conventional pharmaceuticals are the primary culprits for TEN, this report highlights the need for greater awareness of herbal medicine-induced adverse drug reactions. Underreporting of such events, due to lack of awareness among patients and healthcare providers, further complicates the issue. This case emphasizes the need for strengthened regulatory policies and enhanced education to safeguard public health amidst the increasing use of herbal remedies worldwide.

Human ; Female ; Middle Aged: 45-64 Yrs Old ; Medicine, Traditional ; Toxic Epidermal Necrolysis ; Stevens-johnson Syndrome

Hansen’s disease remains a critical health issue in tropical countries like the Philippines. Delayed diagnosis, especially in the context of indiscriminate corticosteroid use, can lead to severe complications. This case highlights the importance of proper referral, ruling out infections, and cautious steroid use.

A 29-year-old Filipino male presented with a 4-year history of erythematous, scaly plaques on his face and scalp, for which he had not sought treatment. One year later, the plaques spread to his trunk, accompanied by arthralgia. Misdiagnosed with psoriasis, he self-medicated with clobetasol and dexamethasone for three years. Over time, he developed signs of Cushing syndrome. Two months before consultation, after a fall, he experienced lower extremity weakness, hypoesthetic plaques on his legs, and blurred vision, but continued using steroids. Upon admission, he was diagnosed with iatrogenic Cushing syndrome. Steroid tapering reduced generalized edema, revealing nodules on his ears and extremities. Slit-skin smear and histopathology confirmed Hansen’s disease. Unfortunately, he succumbed to septic shock before completing treatment.

Misdiagnosis and prolonged steroid use pose risks by masking infections like leprosy. In regions where infectious diseases are prevalent, clinicians should exercise caution before prescribing steroids, as overuse can lead to “therapeutic incognito,” complicating diagnosis. Early referral to dermatologists for undiagnosed or refractory skin lesions is critical in preventing complications. This case emphasizes the importance of educating healthcare providers on judicious steroid use and ruling out infections. Delayed diagnosis of leprosy, as demonstrated here, can lead to severe outcomes, reinforcing the need for timely intervention and thorough patient evaluation.

Human ; Male ; Adult: 25-44 Yrs Old ; Infectious Disease ; Communicable Diseases ; Leprosy